Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cytomegalovirus Infection

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 93 articles:
HTML format



Single Articles


    March 2021
  1. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Unexpected CMV replication kinetics in CMV- donor seropositive recipient seronegative liver transplant recipients receiving preemptive antiviral therapy.
    J Infect Dis. 2021 Mar 23. pii: 6182482. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  2. ALTAF M, Lineburg K, Crooks P, Rehan S, et al
    Pre-transplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study.
    J Infect Dis. 2020 Dec 4. pii: 6019998. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  3. DONADEU L, Revilla-Lopez E, Jarque M, Crespo E, et al
    CMV-specific Cell-Mediated Immunity Predicts High level of CMV Replication after Prophylaxis withdrawal in Lung Transplant Recipients.
    J Infect Dis. 2020 Nov 27. pii: 6007492. doi: 10.1093.
    PubMed     Abstract available


  4. IMLAY H, Dasgupta S, Boeckh M, Stapleton RD, et al
    Risk Factors for Cytomegalovirus Reactivation and Association with Outcomes in Critically Ill Adults with Sepsis: A Pooled Analysis of Prospective Studies.
    J Infect Dis. 2020 Nov 7. pii: 5959850. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  5. SLYKER JA, Guthrie B, Pankau M, Tapia K, et al
    Cytomegalovirus and Epstein-Barr virus viremia are associated with HIV DNA levels in the reservoir of Kenyan infants on antiretroviral therapy.
    J Infect Dis. 2020 Oct 16. pii: 5926738. doi: 10.1093.
    PubMed     Abstract available


  6. COX KS, Zhang L, Freed DC, Tang A, et al
    Functional Evaluation and Genetic Evolution of Human T-cell Responses after Vaccination with a Conditionally Replication-Defective Cytomegalovirus Vaccine.
    J Infect Dis. 2020 Oct 8. pii: 5919748. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  7. NIKOLICH-ZUGICH J
    Cytomegalovirus and Your Health: Not a Matter of the Heart, Nor of Life and Death.
    J Infect Dis. 2020 Sep 10. pii: 5903620. doi: 10.1093.
    PubMed    


  8. CHEN S, Pawelec G, Trompet S, Goldeck D, et al
    Associations of Cytomegalovirus Infection With All-Cause and Cardiovascular Mortality in Multiple Observational Cohort Studies of Older Adults.
    J Infect Dis. 2020 Sep 10. pii: 5903621. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  9. PAEZ-VEGA A, Cantisan S, Aguera ML, Suner M, et al
    Pretransplant CMV-specific T-cell immunity but not dose of antithymocyte globulin is associated with recovery of specific immunity after kidney transplantation.
    J Infect Dis. 2020 Aug 11. pii: 5890921. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  10. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Risk factors for viremia in CMV- recipient seronegative donor seropositive liver transplant recipients who receive preemptive antiviral therapy.
    J Infect Dis. 2020 Jul 29. pii: 5878043. doi: 10.1093.
    PubMed     Abstract available


  11. CHOU S, Song K, Wu J, Bo T, et al
    Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection.
    J Infect Dis. 2020 Jul 29. pii: 5877931. doi: 10.1093.
    PubMed     Abstract available


  12. HASING ME, Pang XL, Mabilangan C, Preiksaitis JK, et al
    Donor cytomegalovirus transmission patterns in solid organ transplant recipients with primary infection.
    J Infect Dis. 2020 Jul 24. pii: 5876001. doi: 10.1093.
    PubMed     Abstract available


  13. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Human Cytomegalovirus (HCMV)-Specific Antibody Response and Development of Antibody-Dependent Cellular Cytotoxicity Against HCMV After Lung Transplantation.
    J Infect Dis. 2020;222:417-427.
    PubMed     Abstract available


  14. KAMINSKI H, Menard C, El Hayani B, Adjibabi AN, et al
    Characterization of a unique gammadelta T cell subset as a specific marker of CMV infection severity.
    J Infect Dis. 2020 Jul 5. pii: 5867506. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  15. SCHWENDINGER M, Thiry G, De Vos B, Leroux-Roels G, et al
    A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus.
    J Infect Dis. 2020 Apr 21. pii: 5821369. doi: 10.1093.
    PubMed     Abstract available


  16. ALI A, Chiuppesi F, Nguyen M, Hausner MA, et al
    Chimeric Antigen Receptors Targeting Human Cytomegalovirus.
    J Infect Dis. 2020 Apr 13. pii: 5819787. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  17. IMLAY H, Limaye AP
    Current Understanding of Cytomegalovirus Reactivation in Critical Illness.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  18. LAUGHLIN C, Chakhtoura N, Beisel C, Dempsey W, et al
    Cytomegalovirus Meeting Summary.
    J Infect Dis. 2020;221.
    PubMed    


  19. RAZONABLE RR, Inoue N, Pinninti SG, Boppana SB, et al
    Clinical Diagnostic Testing for Human Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  20. HAIDAR G, Boeckh M, Singh N
    Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  21. KRAUSE PR, Roberts J
    Scientific and Regulatory Considerations for Efficacy Studies of Cytomegalovirus Vaccines.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  22. PLOTKIN SA
    Preventing Infection by Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  23. ACOSTA E, Bowlin T, Brooks J, Chiang L, et al
    Advances in the Development of Therapeutics for Cytomegalovirus Infections.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  24. MUSSI-PINHATA MM, Yamamoto AY
    Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  25. ROARK HK, Jenks JA, Permar SR, Schleiss MR, et al
    Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  26. KABANI N, Ross SA
    Congenital Cytomegalovirus Infection.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  27. BRITT WJ
    Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  28. PLOTKIN SA, Wang D, Oualim A, Diamond DJ, et al
    The Status of Vaccine Development Against the Human Cytomegalovirus.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  29. NELSON CS, Baraniak I, Lilleri D, Reeves MB, et al
    Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  30. HODOWANEC AC, Pikis A, Singer ME
    The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory Perspective.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  31. LANZIERI TM, Gastanaduy PA, Gambhir M, Plotkin SA, et al
    Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


  32. GRIFFITHS P, Hughes B
    Choice of Study Populations for Vaccines.
    J Infect Dis. 2020;221.
    PubMed     Abstract available


    February 2020
  33. BEHRENS GA, Brehm M, Gross R, Heider J, et al
    Non-invasive determination of CMV serostatus from dried buccal swab samples: assay development, validation and application to 1.2 million samples.
    J Infect Dis. 2020 Feb 13. pii: 5735315. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  34. JO H, Kwon DE, Han SH, Min SY, et al
    De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-infected Tissues: Implications for Primary Letermovir Resistance.
    J Infect Dis. 2019 Dec 5. pii: 5658434. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  35. JAMES SH
    Letermovir Resistance in Hematopoietic Stem Cell Transplant Recipients: The Risks Associated with Cytomegalovirus Prophylaxis.
    J Infect Dis. 2019 Nov 29. pii: 5645460. doi: 10.1093.
    PubMed    


  36. DOUGLAS CM, Barnard R, Holder D, Leavitt R, et al
    Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.
    J Infect Dis. 2019 Nov 29. pii: 5645458. doi: 10.1093.
    PubMed     Abstract available


  37. ZAMORA D, Krantz EM, Green ML, Joncas-Schronce L, et al
    The Cytomegalovirus Humoral Response Against Epithelial Cell Entry-mediated Infection in the Primary Infection Setting after Hematopoietic Cell Transplantation.
    J Infect Dis. 2019 Nov 18. pii: 5627782. doi: 10.1093.
    PubMed     Abstract available


  38. SMITH C, Moraka NO, Ibrahim M, Moyo S, et al
    HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.
    J Infect Dis. 2019 Nov 10. pii: 5618838. doi: 10.1093.
    PubMed     Abstract available


  39. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  40. ROSS S, Pati P, Jensen TL, Goll JB, et al
    Cytomegalovirus genetic diversity following primary infection.
    J Infect Dis. 2019 Oct 8. pii: 5583881. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  41. MEESING A, Germer JJ, Yao JD, Gartner ML, et al
    Differences in Duration and Degree of Cytomegalovirus DNAemia Observed with Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care.
    J Infect Dis. 2019 Aug 31. pii: 5557844. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  42. EVENTOV-FRIEDMAN S, Manor H, Bar-Oz B, Averbuch D, et al
    Saliva real time polymerase chain reaction for targeted screening of congenital cytomegalovirus infection.
    J Infect Dis. 2019 Jul 15. pii: 5532655. doi: 10.1093.
    PubMed     Abstract available


  43. ADLER SP, Lewis N, Conlon A, Christiansen MP, et al
    Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects.
    J Infect Dis. 2019;220:411-419.
    PubMed     Abstract available


    June 2019
  44. PIRET J, Schibler M, Pham VD, Hantz S, et al
    Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.
    J Infect Dis. 2019 Jun 13. pii: 5519111. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  45. SACCOCCIO FM, Jenks JA, Itell HL, Li SH, et al
    Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
    J Infect Dis. 2019 May 20. pii: 5492326. doi: 10.1093.
    PubMed     Abstract available


  46. SUAREZ NM, Wilkie GS, Hage E, Camiolo S, et al
    Human Cytomegalovirus Genomes Sequenced Directly from Clinical Material: Variation, Multiple-Strain Infection, Recombination and Gene Loss.
    J Infect Dis. 2019 May 2. pii: 5485299. doi: 10.1093.
    PubMed     Abstract available


  47. SUAREZ NM, Musonda KG, Escriva E, Njenga M, et al
    Multiple-Strain Infections of Human Cytomegalovirus with High Genomic Diversity are Common In Breast Milk from HIV-Positive Women in Zambia.
    J Infect Dis. 2019 May 2. pii: 5485308. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  48. LIMAYE AP, Green ML, Edmison BC, Stevens-Ayers T, et al
    Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis.
    J Infect Dis. 2019 Apr 26. pii: 5480166. doi: 10.1093.
    PubMed     Abstract available


  49. KAMINSKI H, Jarque M, Halfon M, Taton B, et al
    Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
    J Infect Dis. 2019 Apr 26. pii: 5480114. doi: 10.1093.
    PubMed     Abstract available


  50. EL HADDAD L, Ariza-Heredia E, Chemaly RF
    Reply to Gimenez et al.
    J Infect Dis. 2019;219:1512-1513.
    PubMed    


    February 2019
  51. BARANIAK I, Kern F, Holenya P, Griffiths P, et al
    Original antigenic sin shapes the immunological repertoire evoked by HCMV gB-MF59 vaccine in seropositive recipients.
    J Infect Dis. 2019 Feb 27. pii: 5366424. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  52. MUENCHHOFF M, Adland E, Roider J, Kloverpris H, et al
    Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children.
    J Infect Dis. 2019 Jan 8. pii: 5280900. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  53. GIMENEZ E, Solano C, Luis Pinana J, Poch M, et al
    Cytomegalovirus-specific CD8+ T cell levels at viral DNAemia onset fail to predict the eventual need for preemptive antiviral therapy in allogeneic hematopoietic stem cell transplant recipients.
    J Infect Dis. 2018 Dec 29. pii: 5266810. doi: 10.1093.
    PubMed    


  54. MARSICO C, Aban I, Kuo H, James SH, et al
    Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.
    J Infect Dis. 2018 Dec 7. pii: 5232568. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  55. EL HADDAD L, Ariza-Heredia E, Shah DP, Jiang Y, et al
    The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.
    J Infect Dis. 2018 Oct 6. pii: 5122855. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  56. CHANOUZAS D, Sagmeister M, Faustini S, Nightingale P, et al
    Subclinical reactivation of cytomegalovirus drives CD4+CD28null T-cell expansion and impaired immune response to pneumococcal vaccination in ANCA-associated vasculitis.
    J Infect Dis. 2018 Aug 9. pii: 5068409. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  57. PLOTKIN SA
    Seroconversion for Cytomegalovirus Infection during Pregnancy and Fetal Infection in a Highly Seropositive Population: "The BraCHS Study, " by Mussi-Pinhata et al.
    J Infect Dis. 2018 Jun 4. pii: 5032599. doi: 10.1093.
    PubMed    


  58. MUSSI-PINHATA MM, Yamamoto AY, Aragon DC, Duarte G, et al
    Seroconversion for Cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: "The BraCHS Study".
    J Infect Dis. 2018 Jun 4. pii: 5032598. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  59. JOHNSON EL, Boggavarapu S, Johnson ES, Lal A, et al
    HCMV enhances placental susceptibility and replication of HIV-1 which may facilitate in utero HIV-1 transmission.
    J Infect Dis. 2018 May 31. pii: 5026120. doi: 10.1093.
    PubMed     Abstract available


  60. BURTON CE, Sester M, Robinson JL, Eurich DT, et al
    Assigning Cytomegalovirus (CMV) Status in Children Awaiting Organ Transplant: Viral Shedding, CMV-Specific T-cells and CD27-CD28-CD4+ T-cells.
    J Infect Dis. 2018 May 24. pii: 5003041. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  61. FALK JJ, Winkelmann M, Stohr D, Alt M, et al
    Identification of "elite" blood donors with broad and potent neutralizing activity against the human cytomegalovirus.
    J Infect Dis. 2018 Apr 19. pii: 4976609. doi: 10.1093.
    PubMed     Abstract available


  62. CHENEAU C, Coulon F, Porkolab V, Fieschi F, et al
    Fine-mapping the interaction between DC-SIGN and the cytomegalovirus envelope glycoprotein B.
    J Infect Dis. 2018 Apr 10. pii: 4965770. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  63. SCHLEISS MR
    Searching for a Serological Correlate of Protection for a CMV Vaccine.
    J Infect Dis. 2018 Mar 8. pii: 4924674. doi: 10.1093.
    PubMed    


  64. BARANIAK I, Kropff B, McLean GR, Pichon S, et al
    Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia.
    J Infect Dis. 2018 Mar 8. pii: 4924673. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  65. MARGOLICK JB, Bream JH, Nilles TL, Li H, et al
    Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study.
    J Infect Dis. 2018 Feb 26. pii: 4909741. doi: 10.1093.
    PubMed     Abstract available


  66. ROSS SA, Michaels MG, Ahmed A, Palmer AL, et al
    Contribution of Breastfeeding to False Positive Saliva PCR for Newborn Congenital Cytomegalovirus Screening.
    J Infect Dis. 2018 Feb 1. pii: 4833232. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  67. HUANG Y, Guo X, Song Q, Wang H, et al
    Cytomegalovirus shedding in healthy seropositive female college students: a six-month longitudinal study.
    J Infect Dis. 2017 Dec 25. pii: 4774530. doi: 10.1093.
    PubMed     Abstract available


  68. GUBERINA H, da Silva Nardi F, Tomoya Michita R, Dolff S, et al
    Susceptibility of HLA-E*01:03 allele carriers to develop Cytomegalovirus replication after living-donor kidney transplantation.
    J Infect Dis. 2017 Dec 8. pii: 4712146. doi: 10.1093.
    PubMed     Abstract available


  69. VIETZEN H, Pollak K, Honsig C, Jaksch P, et al
    NKG2C Deletion is a Risk Factor for Human Cytomegalovirus-Viremia and Disease after Lung Transplantation.
    J Infect Dis. 2017 Dec 6. pii: 4695493. doi: 10.1093.
    PubMed     Abstract available


    September 2017
  70. PEI XY, Zhao XY, Chang YJ, Liu J, et al
    Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Abstract available


  71. DOWD JB, Bosch JA, Steptoe A, Jayabalasingham B, et al
    Persistent Herpesvirus Infections and Telomere Attrition Over 3 Years in the Whitehall II Cohort.
    J Infect Dis. 2017;216:565-572.
    PubMed     Abstract available


    August 2017
  72. MOYLAN DC, Pati SK, Ross SA, Fowler KB, et al
    Breast Milk HCMV viral load is associated with the establishment of breast milk CMV-pp65-specific CD8 T cells in Human CMV infected Mothers.
    J Infect Dis. 2017 Aug 29. doi: 10.1093.
    PubMed     Abstract available


    July 2017
  73. HENRICH TJ, Hobbs KS, Hanhauser E, Scully E, et al
    Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
    J Infect Dis. 2017;216:254-262.
    PubMed     Abstract available


    May 2017
  74. SCHOCH J, Rohrer TR, Kaestner M, Abdul-Khaliq H, et al
    Quantitative, Phenotypical, and Functional Characterization of Cellular Immunity in Children and Adolescents With Down Syndrome.
    J Infect Dis. 2017;215:1619-1628.
    PubMed     Abstract available


    April 2017
  75. FORMAN MS, Vaidya D D, Bolorunduro O, Diener-West M, et al
    Cytomegalovirus (CMV) kinetics following primary infection in healthy women.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Abstract available


  76. YONG MK, Cameron PU, Slavin M, Morrissey CO, et al
    Identifying Cytomegalovirus (CMV) complications using the Quantiferon-CMV assay after Allogeneic Hematopoietic Stem Cell Transplantation.
    J Infect Dis. 2017 Apr 18. doi: 10.1093.
    PubMed     Abstract available


  77. TONG Y, Pang XL, Mabilangan C, Preiksaitis JK, et al
    Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  78. HAGE E, Wilkie GS, Linnenweber-Held S, Dhingra A, et al
    Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole genomic sequencing directly from clinical specimens.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  79. JANSEN MAE, van den Heuvel D, Jaddoe VWV, Moll HA, et al
    No Interactive Effects of Sex and Persistent Cytomegalovirus on Immune Phenotypes in Young Children: The Generation R Study.
    J Infect Dis. 2017;215:883-888.
    PubMed     Abstract available


  80. YOUNG VP, Mariano MC, Tu CC, Allaire KM, et al
    Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.
    J Infect Dis. 2017;215:874-882.
    PubMed     Abstract available


    February 2017
  81. MAECKER HT
    Opening the Door on the CMV Immune Response in Aging.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed    


  82. BAJWA M, Vita S, Vescovini R, Larsen M, et al
    CMV-specific T-cell responses at older ages: broad responses with a large central memory component may be key to long-term survival.
    J Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed    


  83. BOECKH M, Stevens-Ayers T, Travi G, Huang ML, et al
    Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed    


  84. GRIFFITHS P
    Diagnosis of cytomegalovirus pneumonitis following stem cell transplantation: addressing the Ying and Yang of molecular methods.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed    


  85. JANSEN MA, Heuvel DV, Jaddoe VW, Moll HA, et al
    Gender-specific differences in immune phenotypes of young children are not affected by persistent cytomegalovirus infection. The Generation R Study.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed    


  86. YOUNG VP, Mariano MC, Tu CC, Allaire KM, et al
    Human Cytomegalovirus (HCMV) modulates the host environment with vIL-10 in peripheral blood.
    J Infect Dis. 2017 Feb 1. doi: 10.1093.
    PubMed    


    December 2016
  87. EVANS C, Chasekwa B, Rukobo S, Govha M, et al
    CMV acquisition and inflammation in HIV-exposed uninfected Zimbabwean infants.
    J Infect Dis. 2016 Dec 23. pii: jiw630. doi: 10.1093.
    PubMed     Abstract available


  88. HAN SH, Kumar D, Ferreira VH, Egli A, et al
    Human microRNA responses predict cytomegalovirus replication following solid organ transplantation.
    J Infect Dis. 2016 Dec 21. pii: jiw596. doi: 10.1093.
    PubMed     Abstract available


  89. BIALAS KM, Westreich D, Cisneros de la Rosa E, Nelson CS, et al
    Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.
    J Infect Dis. 2016;214:1916-1923.
    PubMed     Abstract available


    October 2016
  90. SCHIRDEWAHN T, Grabowski J, Sekyere SO, Bremer B, et al
    The third signal cytokine IL-12 rather than immune checkpoint inhibitors contribute to the functional restoration of hepatitis D virus-specific T-cells.
    J Infect Dis. 2016.
    PubMed     Abstract available


  91. GIANELLA S, Letendre S
    Cytomegalovirus and HIV: A Dangerous Pas de Deux.
    J Infect Dis. 2016;214 Suppl 2:S67-74.
    PubMed     Abstract available


    September 2016
  92. MAYER BT, Matrajt L, Casper C, Krantz EM, et al
    Dynamics of persistent oral cytomegalovirus shedding during primary infection in Ugandan infants.
    J Infect Dis. 2016.
    PubMed     Abstract available


    May 2016
  93. DAUBY N, Sartori D, Kummert C, Lecomte S, et al
    Limited Effector Memory B-Cell Response to Envelope Glycoprotein B During Primary Human Cytomegalovirus Infection.
    J Infect Dis. 2016;213:1642-50.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: